Skip to Content
Merck
CN
  • Design, synthesis, and biological activities of pyrrolylethanoneamine derivatives, a novel class of monoamine oxidases inhibitors.

Design, synthesis, and biological activities of pyrrolylethanoneamine derivatives, a novel class of monoamine oxidases inhibitors.

Journal of medicinal chemistry (2005-06-25)
Roberto Di Santo, Roberta Costi, Alessandra Roux, Marino Artico, Olivia Befani, Tiziana Meninno, Enzo Agostinelli, Paola Palmegiani, Paola Turini, Roberto Cirilli, Rosella Ferretti, Bruno Gallinella, Francesco La Torre
ABSTRACT

Pyrrolylethanoneamines 1-12, 18-23 and related amino alcohols 13-15, 24-27 were synthesized and tested against monoamine oxidases A and B (MAO-A and MAO-B) enzymes. In general, aminoketones 1-12, 18-23 were found to be potent and selective MAO-A inhibitors. In particular, 18 was more potent and selective against the MAO-A isoenzyme than reference drugs. Interestingly, amino alcohol 25 selectively inhibited MAO-B enzyme and could be a lead compound for designing more potent and selective MAO-B inhibitors.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Toloxatone, ≥98% (HPLC), solid